US Stock MarketDetailed Quotes

CNTB Connect Biopharma

Watchlist
  • 1.1400
  • +0.1700+17.53%
Close Dec 27 16:00 ET
  • 1.1400
  • 0.00000.00%
Post 17:06 ET
62.82MMarket Cap-2.92P/E (TTM)

Connect Biopharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Total revenue
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-44.34%64.85M
20.66%116.51M
229.15%96.56M
81.18%29.34M
16.19M
Selling and administrative expenses
-30.24%14.52M
9.42%20.81M
160.32%19.01M
426.16%7.3M
--1.39M
-General and administrative expense
-30.24%14.52M
9.42%20.81M
160.32%19.01M
426.16%7.3M
--1.39M
Research and development costs
-46.28%51.91M
20.04%96.63M
248.44%80.5M
51.90%23.1M
--15.21M
Other operating expenses
-70.08%-1.58M
68.51%-929K
-175.77%-2.95M
-163.92%-1.07M
---405.33K
Operating profit
44.34%-64.85M
-20.66%-116.51M
-229.15%-96.56M
-81.18%-29.34M
-16.19M
Net non-operating interest income expense
76.69%2.69M
1,592.22%1.52M
127.02%90K
-330.05%-333.06K
144.78K
Non-operating interest income
75.78%2.71M
1,491.75%1.54M
-11.61%97K
-27.97%109.75K
--152.36K
Non-operating interest expense
9.52%23K
200.00%21K
8.89%7K
-15.13%6.43K
--7.57K
Total other finance cost
----
----
----
--436.38K
----
Other net income (expense)
198.75%2.77M
97.34%-2.81M
-17.78%-105.53M
-1,012.60%-89.6M
-8.05M
Gain on sale of security
65.32%2.88M
101.67%1.74M
-16.55%-104.43M
-1,012.60%-89.6M
---8.05M
Special income (charges)
--0
---4.7M
--0
--0
----
-Less:Impairment of capital assets
--0
--4.7M
--0
--0
----
Other non- operating income (expenses)
-167.33%-101K
113.65%150K
---1.1M
----
----
Income before tax
49.59%-59.38M
41.69%-117.79M
-69.36%-202M
-394.89%-119.27M
-24.1M
Income tax
-59.73%120K
12.03%298K
266K
0
0
Net income
49.61%-59.5M
41.62%-118.09M
-69.59%-202.27M
-394.89%-119.27M
-24.1M
Net income continuous Operations
49.61%-59.5M
41.62%-118.09M
-69.59%-202.27M
-394.89%-119.27M
---24.1M
Minority interest income
Net income attributable to the parent company
49.61%-59.5M
41.62%-118.09M
-69.59%-202.27M
-394.89%-119.27M
-24.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
49.61%-59.5M
41.62%-118.09M
-69.59%-202.27M
-394.89%-119.27M
-24.1M
Basic earnings per share
49.77%-1.08
44.59%-2.15
-75.48%-3.88
-412.09%-2.2111
-0.4318
Diluted earnings per share
49.77%-1.08
44.59%-2.15
-75.48%-3.88
-412.09%-2.2111
-0.4318
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
--
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Total revenue 00000
Operating revenue --0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -44.34%64.85M20.66%116.51M229.15%96.56M81.18%29.34M16.19M
Selling and administrative expenses -30.24%14.52M9.42%20.81M160.32%19.01M426.16%7.3M--1.39M
-General and administrative expense -30.24%14.52M9.42%20.81M160.32%19.01M426.16%7.3M--1.39M
Research and development costs -46.28%51.91M20.04%96.63M248.44%80.5M51.90%23.1M--15.21M
Other operating expenses -70.08%-1.58M68.51%-929K-175.77%-2.95M-163.92%-1.07M---405.33K
Operating profit 44.34%-64.85M-20.66%-116.51M-229.15%-96.56M-81.18%-29.34M-16.19M
Net non-operating interest income expense 76.69%2.69M1,592.22%1.52M127.02%90K-330.05%-333.06K144.78K
Non-operating interest income 75.78%2.71M1,491.75%1.54M-11.61%97K-27.97%109.75K--152.36K
Non-operating interest expense 9.52%23K200.00%21K8.89%7K-15.13%6.43K--7.57K
Total other finance cost --------------436.38K----
Other net income (expense) 198.75%2.77M97.34%-2.81M-17.78%-105.53M-1,012.60%-89.6M-8.05M
Gain on sale of security 65.32%2.88M101.67%1.74M-16.55%-104.43M-1,012.60%-89.6M---8.05M
Special income (charges) --0---4.7M--0--0----
-Less:Impairment of capital assets --0--4.7M--0--0----
Other non- operating income (expenses) -167.33%-101K113.65%150K---1.1M--------
Income before tax 49.59%-59.38M41.69%-117.79M-69.36%-202M-394.89%-119.27M-24.1M
Income tax -59.73%120K12.03%298K266K00
Net income 49.61%-59.5M41.62%-118.09M-69.59%-202.27M-394.89%-119.27M-24.1M
Net income continuous Operations 49.61%-59.5M41.62%-118.09M-69.59%-202.27M-394.89%-119.27M---24.1M
Minority interest income
Net income attributable to the parent company 49.61%-59.5M41.62%-118.09M-69.59%-202.27M-394.89%-119.27M-24.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 49.61%-59.5M41.62%-118.09M-69.59%-202.27M-394.89%-119.27M-24.1M
Basic earnings per share 49.77%-1.0844.59%-2.15-75.48%-3.88-412.09%-2.2111-0.4318
Diluted earnings per share 49.77%-1.0844.59%-2.15-75.48%-3.88-412.09%-2.2111-0.4318
Dividend per share
Currency Unit USDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.